<DOC>
	<DOCNO>NCT01993966</DOCNO>
	<brief_summary>Urothelial carcinoma ( UC ) common cancer urinary tract . Patients metastatic UC usually treat systemic chemotherapy . There still exist 30 % 50 % advanced UC responsive cisplatin-based chemotherapy ; prognosis patient metastatic UC remain poor .</brief_summary>
	<brief_title>EGCG Modulate Cytotoxic Effects Chemotherapeutic Agents Human Urothelial Carcinoma Cells</brief_title>
	<detailed_description>( - ) -epigallocatechin -3-gallate ( EGCG ) abundant polyphenol compound green tea , represent ~16.5 % water-extractable fraction . EGCG various bioactivities bind regulate wide range molecular involve cell cycle , signal transduction , protein degradation . However , anticancer effect EGCG UC thoroughly explore . Our preliminary data show EGCG alone inhibit cell proliferation induce apoptosis activation caspases PARP time dependent manner . Moreover , EGCG enhance cytotoxicity several chemotherapeutic drug vitro . The underlying mechanism seem associate Akt ERK pathway . We also check Akt ERK protein level immunohistochemical stain clinically chemoreistant bladder urothelial carcinoma specimen prove vitro finding . We confirm effect chemotherapeutic drug combine EGCG UC vivo via xenograft model . The specific aim study : 1 . To explore anti-tumor effect EGCG human UC cell elucidate possible mechanism . 2 . To study combinative cytotoxic effect EGCG chemotherapeutic agent cisplatin , doxorubicin gemcitabine UC cell ; moreover , investigate underlying mechanism . 3 . To investigate expression level phospho-Akt phospho-ERK clinically chemoreistant bladder urothelial carcinoma specimen confirm find clinical event . . 4 . To prove vitro finding confirm combinative efficacy EGCG chemotherapeutic agent vivo use xenograft animal model . 5 . To establish novel therapeutic strategy treatment UC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Antineoplastic Agents</mesh_term>
	<criteria>In January 2008 December 2012 National Taiwan University Hospital surgery ( radical resection kidney ureter bladder removal ) urothelial carcinoma histopathology specimens patient willing participate study subject describe consent Book signer . In January 2008 December 2012 National Taiwan University Hospital surgery ( radical resection kidney ureter bladder removal ) urothelial carcinoma histopathology specimens patient reluctant join researcher</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Urothelial carcinoma ( UC ) ,</keyword>
	<keyword>( - ) -epigallocatechin-3-gallate ( EGCG ) ,</keyword>
	<keyword>chemotherapy ,</keyword>
	<keyword>cytotoxicity ,</keyword>
	<keyword>drug resistance ,</keyword>
	<keyword>xenograft .</keyword>
</DOC>